Promoting Awareness on Causes and Treatment
Lung cancer is the world’s foremost cause of cancer-related fatalities, with more deaths each year than breast, colon, and prostate cancers combined. According to the World Health Organization data, it accounts for roughly 2.09 million fatalities each year on average (WHO). Even though new research and experiments continue to produce advancements in the study and treatment of lung cancer, it has one of the lowest survival rates compared to breast or prostate cancer, owing to a lack of financing.
On August 1, World Lung Cancer Day is commemorated to promote awareness about the causes and treatment of lung cancer, as well as to highlight the problems that a lack of adequate research funding may bring. The Forum of International Respiratory Societies, in conjunction with the International Association for the Study of Lung Cancer and the American College of Chest Physicians, launched this campaign in 2012. The campaign considers everyone who has been diagnosed with the condition, as well as those who have recovered, and seeks to offer them with assistance. The IASLC World Conference on Lung Cancer (WCLC) is the world’s biggest organisation dedicated solely to lung cancer.
Causes and Early Detection
While most people are aware that smoking is the leading cause of lung cancer, which accounts for 80% of all occurrences, other less well-known risk factors include the environment and heredity. Lung cancer has been related to radon, asbestos, arsenic, beryllium, and uranium exposure in the environment. A history of cancer in another region of the body, age, family history, radiation to the chest area, and lung disorders such as chronic obstructive pulmonary disease all raise the risk of lung cancer. Early detection and treatment is vital for effective treatment of lung cancer. However, only 15% of therapy is available through public health systems in low-income nations, where survival rates are substantially lower than the global average. More than 90% of high-income countries report having critical access to healthcare.
Changes in mucus, chest or back discomfort, coughing up blood, and trouble swallowing are all indications of lung cancer. Chest x-rays, CT and PET scans, bronchoscopy, and needle biopsies are some of the tests that can be performed to detect lung cancer. If one is over 55 and a current or former smoker, they should opt for a low-dose CT scan screening that can detect lung cancer in its early stages.
Doxorubicin: An anthracycline of Chemotheraphy
Doxorubicin is an anti-cancer drug, classified as an ‘anthracycline antibiotic’, prescribed by a doctor to treat certain malignancies. It can be used alone or in combination with other anticancer drugs. It is multi-agent adjuvant chemotherapy used on women who have axillary lymph node involvement after primary breast cancer resection.
It is injected as an intravenous (IV) infusion either through a central line or a peripheral venous line over a period of several minutes. A health care provider administers this medicine by injecting it into a vein. It can also be administered through a central catheter line as a continuous infusion. The dose is determined by one’s medical condition, body size, and therapeutic response. It does not come in tablet form.
Prioritizing good health, globally
Commemorating almost three decades of excellence, Shubham Pharmachem is a top merchant export organization in the country when it comes to manufacturing Active Pharmaceutical Ingredients (API), herbal extracts, nutraceutical ingredients, cosmetic ingredients and other life-saving medicines.
The dynamic organization has built a strong reputation as a market-driven company. It is focused on customer service and is capable of offering a wide range of affordable pharmaceutical products. It continues to expand its product portfolio to benefit patients, prescribers, and other stakeholders in the healthcare system.
For more details, visit www.shubham.co.in
Shubham Pharmachem’s blog posts have been written with the information gathered from approved medical journals and websites online. Our research and technical team strive to provide relevant information through such articles. However, we strongly advise readers to not consume or administer any medication without prior consultation with their doctor.
- Read more – https://goldcopd.org/world-lung-cancer-day-august-1st-2020/
- Read at – https://www.lung.org/lung-force/about-lung-force/featured-campaigns/world-lung-cancer-day
- Read more – https://www.thoracic.org/about/newsroom/press-releases/journal/2020/world-lung-cancer-day-2020.php
- Read more – https://www.webmd.com/drugs/2/drug-7750/doxorubicin-intravenous/details
- Read more – https://pubmed.ncbi.nlm.nih.gov/27103205/